Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-02-27 @ 4:06 PM
Study NCT ID:
NCT04959305
Status:
COMPLETED
Last Update Posted:
2022-07-14
First Post:
2021-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypertension | View |
Keywords: